1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Group 2 Pulmonary Hypertension: new trials by email Literature Review of Group 2 Pulmonary Hypertension trials Research Report on Group 2 Pulmonary Hypertension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Combination therapy, Monotherapy - Combined Pre- and Post-capillary Pulmonary Hypertension, CpcPH | Phase 4 | Recruiting | Gachon University Gil Medical Center | 64 | 2025-11-24 | 2026-04-03 |
Gachon University Gil Medical Center (1)
South Korea (1)